Thermedical, a Waltham-based medical equipment company, said Wednesday that it has received Food & Drug Administration clearance to market its technology for the coagulation and ablation of soft tissue during certain surgical procedures. “Receiving FDA clearance is a significant milestone for Thermedical as it will facilitate our plans to carry out a series of clinical trials to evaluate the efficacy of our system for treating large, solid tumors, including liver cancer,” Thermedical president Michael G. Curley said.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help